Advanced and recurrent gynecological cancers lack effective treatment and have poor
prognosis. Besides, there is urgent need for conservative treatment for fertility protection of …

Cervical cancer (CC) is an important public health problem for women, and perspectives
and information regarding its prevention and treatment are quickly evolving. Human …

Background Implementation of high-risk human papillomavirus (hrHPV) screening has
greatly reduced the incidence and mortality of cervical cancer. However, a triage strategy …

DNA methylation plays a crucial role in tumorigenesis and tumor progression, sparking
substantial interest in the clinical applications of cancer DNA methylation biomarkers …

Cancer is the leading cause of death worldwide. Early detection of cancer can lower the
mortality of all types of cancer; however, effective early-detection biomarkers are lacking for …

The primary reason for high mortality rates among cancer patients is metastasis, where
tumor cells migrate through the bloodstream from the original site to other parts of the body …

Endometrial cancer (EC) is one of the most common gynecologic cancers in developed
countries. Presently, it is imperative to develop a reliable, noninvasive, or minimally invasive …

BACKGROUND Differentiating malignant from nonmalignant body fluids remains a clinical
challenge because of the unsatisfying performance of conventional cytology. We aimed to …

Background Urothelial carcinoma (UC) is the second most common urological malignancy.
Despite numerous molecular markers have been evaluated during the past decades, no …

Aberrant DNA methylation gets involved in cancer initiation, progression, and recurrence,
which in turn makes it an ideal cancer biomarker. Various methylation markers or their …